Topics and Speakers: Including China into Your Drug Development Strategy: Why, When and How? Jiansong Yang, PhD, CSO, Tigermed Dr. Jiansong Yang is the Chief Scientific Officer of Tigermed, which is the largest clinical CRO in China. He’s also the Founder and CEO of Mosim (acquired by Tigermed company), which focuses on drug development strategy, clinical study design, and PK/PD data analysis. Dr. Yang has over 15 years of experience in the pharmaceutical industry, specializing in early drug development and clinical study design. Prior to Mosim, he was Director of Clinical Pharmacology [...]

Title: The Chinese American Experience: Evolving Tensions in US-China Relations Time: Thursday, September 24, 8:00-9:00 PM, EDT Speaker: Brian A. Sun Of Counsel, Jones Day; Investigations & White Collar Defense, Business & Tort Litigation Christopher K. Pelham Of Counsel, Jones Day; Global Disputes, Investigations & White Collar Defense, Technology Highlights :  US  government national security concerns  IP/trade secrets theft  Organizing and responding to the “loyalty” challenges raised by the current environment and the return of the Fifties type scrutiny and persecution of Asian Pacific Americans Register Here Speaker's Bio Brian Sun has earned [...]

Register here Arm yourself with legal and regulatory knowledge to navigate successfully in the new US-China business environment About this Event Zoom meeting information will be sent to your email address after registration. Speakers: Joshua Gruenspecht, Partner at WSGR Jennifer Fang, Partner at WSGR Zhipping (Louis) Liu, Partner at Liu, Chen Hoffman, LLP Yong Chen, Partner at Liu, Chen, Hoffman, LLP Topics by each speaker: 1. Joshua Gruenspecht: · New CFIUS rules and implications for Chinese investments in the US in the life sciences industry, as well as licensing into China, and JV in China; · How [...]

Speakers Rebecca Chan, Partner, Audit & Assurance, Deloitte China Lawrence Jin, Partner, Audit & Assurance, Deloitte China Danny Wang, Managing Director, Audit & Assurance, Deloitte & Touche LLP Lili Zheng, Partner, International Tax, Deloitte Tax LLP   Agenda Legislative updates Capital market updates and exit strategy planning HK, Mainland China, US IPO trends & market comparison Panel Discussion – what you have seen from the market How to recover and thrive in the current market situation Corporate structures and IP planning Global incentives for R&D Register Here Speakers: Rebecca Chan National Capital Market Leader, China; Partner, [...]

Register Here COVID-19 has wrought shutdowns and thousands of global deaths for almost six months. People are anxiously waiting for the chance to return to normal routines. Vaccines may bring that hope. Many companies have joined the race and began the development of COVID-19 vaccines. Some frontrunners have entered clinical trials. What are the differences between these vaccines? How to develop a vaccine in such a short time, and what can we learn from this COVID-19 pandemic? Join us in this webinar. Dr. Li will answer these questions and share experiences on vaccine development strategies! Speaker: Dr. Hangwen Li is [...]